In the above article, the authors have found an error in Figure 1 .
In the above article, the authors have found an error in Figure 1 .
The correct P-values that are stated in the Results section are P ¼ 0.0036 (comparing DFG-mIL-12 with HBSS) and P ¼ 0.0197 (comparing DFG-mIL-12 with DFG-eGFP).
The correct figure is shown below.
The authors would like to apologize for this mistake. 10 6 ) were injected via the tail vein into recipient 129/Sv male mice without prior bone marrow ablation 3 days following tumor cell injection. The experimental scheme is shown in (a). Serum IL-12 level was monitored by ELISA (p70/p40) at 3-day intervals following retroviral vector-transduced BMC treatment (MOI ¼ 2) (b). At day 21 after treatment, lungs were removed and fixed in Bouin's solution. Formation of lung metastatic colonies was quantified in (c). Femurs were fixed and stained with H&E. Formation of bone metastasis at low and high magnification in mice treated with DFG-eGFPtransduced BMC (d and e, respectively), and in mice treated with DFG-mIL-12-transduced BMC (f and g, respectively). Data are representative of three mice per group per experiment of two independently performed experiments. H&E, hematoxylin and eosin stain. 
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